Cite
Brevicillin, a novel lanthipeptide from the genus Brevibacillus with antimicrobial, antifungal, and antiviral activity.
MLA
Singh, Shelley Sardul, et al. “Brevicillin, a Novel Lanthipeptide from the Genus Brevibacillus with Antimicrobial, Antifungal, and Antiviral Activity.” Journal of Applied Microbiology, vol. 134, no. 3, Mar. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1093/jambio/lxad054.
APA
Singh, S. S., Sharma, D., Singh, C., Kumar, S., Singh, P., Sharma, A., Das, D. K., Pinnaka, A. K., Thakur, K. G., Ringe, R. P., & Korpole, S. (2023). Brevicillin, a novel lanthipeptide from the genus Brevibacillus with antimicrobial, antifungal, and antiviral activity. Journal of Applied Microbiology, 134(3), 1–15. https://doi.org/10.1093/jambio/lxad054
Chicago
Singh, Shelley Sardul, Deepika Sharma, Charandeep Singh, Sahil Kumar, Prashant Singh, Anshul Sharma, Deepjyoti Kumar Das, et al. 2023. “Brevicillin, a Novel Lanthipeptide from the Genus Brevibacillus with Antimicrobial, Antifungal, and Antiviral Activity.” Journal of Applied Microbiology 134 (3): 1–15. doi:10.1093/jambio/lxad054.